Results 241 to 250 of about 91,779 (296)

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

Transmission Risk of Intentional Transplantation of Kidneys From Donors With Active Hepatitis B to Recipients Without Active Hepatitis B: A Systematic Review and Meta-Analysis. [PDF]

Transplantation
Waller KMJ, De La Mata N, Hedley JA, Sharma T, Davies R, Garrett E, White S, Rawlinson W, Stelzer-Braid S, Wyburn K, Webster AC.   +10 more
europepmc   +1 more source

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

Trace Amine-associated Receptors (TAARs): Candidate Targets in the Treatment of Bipolar Disorders. [PDF]

Actas Esp Psiquiatr
Alnefeesi Y, Murtazina RZ, Gainetdinov RR.   +2 more
europepmc   +1 more source

Age‐Related Characteristics of SYT1‐Associated Neurodevelopmental Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives We describe the clinical manifestations and developmental abilities of individuals with SYT1‐associated neurodevelopmental disorder (Baker‐Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations ...
Sam G. Norwitz, Josefine Eck, Joel S. Winston, Kate Baker   +3 more
wiley   +1 more source

Cognitive impairment is associated with altered blood cell profiles in aggressive lymphoma. [PDF]

Support Care Cancer
McCaffrey D, Gates P, Dhillon HM, Wilson C, Vardy JL, Weickert CS, Walker AK.   +6 more
europepmc   +1 more source

Oncologist perspectives on the time toxicity of palliative systemic treatments for advanced cancer. [PDF]

JNCI Cancer Spectr
Stevens SX, Addo IY, El-Katateny E, Rollins B, De Abreu Lourenço R, Booth CM, Shaw J, Vardy JL.   +7 more
europepmc   +1 more source

Pathogen-reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange. [PDF]

Transfusion
Tupin F, Mouriaux C, Hechler B, Kaastrup K, Yegneswaran S, Corash L, Mangin PH.   +6 more
europepmc   +1 more source

Two-year decline in performance on the Cerebellar Cognitive Affective Syndrome Scale in spinocerebellar ataxias. [PDF]

J Neurol
Selvadurai LP, Lo Giudice C, Wallis S, Morgan J, Kumar KR, Szmulewicz DJ, Harding IH.   +6 more
europepmc   +1 more source